The FDA recently approved our personalized medicine for two different indications: ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumors.
?? of 40 moments published
Tell us what you think about our company, products, or website.
The important thing in science is not so much to obtain new facts as to discover new ways of thinking about them.